# Protective Effect of Sivelestat Against Negative Pulmonary Function and Organ Dysfunction After Cardiovascular Surgery (PANDA VI)

> **NCT06195267** · NA · RECRUITING · sponsor: **Nanjing Medical University** · enrollment: 500 (estimated)

## Conditions studied

- Aortic Dissection
- Systemic Inflammatory Response Syndrome
- Cardiovascular Diseases (CVD)

## Interventions

- **DRUG:** Sivelestat
- **DRUG:** Blank control

## Key facts

- **NCT ID:** NCT06195267
- **Lead sponsor:** Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2024-11-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06195267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06195267, "Protective Effect of Sivelestat Against Negative Pulmonary Function and Organ Dysfunction After Cardiovascular Surgery (PANDA VI)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06195267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*